Sage Journals: Discover world-class research

Retricted access

Case report

First published 2018-12

Meeting with triumph and disaster: Osimertinib in T790M-unknown CNS progression in EGFR -mutated non-small cell lung cancer

Francesco Facchinetti, Francesca Bozzetti, Roberta Minari [...]

Tumori Journal

Open access

Research article

First published 2025-1

Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI

David Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde [...]

Cancer Biomarkers

Open access

Review article

First published 2024

Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Jietao Ma, Letian Huang, Chengbo Han

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Epidermal growth factor receptor-Mutated Non-small-cell Lung Cancer with Intracranial Progressions and Stable Extracranial Diseases Benefit from Osimertinib Regardless of T790M Mutational Status

Jun Liao, Yihua Huang, Jiadi Gan [...]

Cancer Control

Open access

Review article

First published 2016-12

Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience

Ivana Sullivan, David Planchard

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2022

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2017-6

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale,evidence and place in therapy

Biagio Ricciuti, Sara Baglivo, Luca Paglialunga [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2014-01

Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Paola Bordi, Marcello Tiseo, Beatrice Bortesi [...]

Tumori Journal

Search results